Literature DB >> 836115

Anemia in hemodialysis patients.

M R Higgins, M Grace, R A Ulan, D S Silverberg, K B Bettcher, J B Dossetor.   

Abstract

The association between anemia and chronic renal failure has been recognized since the early 19th century. With the introduction of regular dialysis treatment, an understanding of all aspects of this uremic complication has become of great importance, including an appreciation of the hazards of multiple blood transfusions. This analysis of hemoglobin levels and transfusion requirements in 84 dialysis patients focuses specific attention on hemolytic mechanisms, blood loss, and the effect of bilateral nephrectomy on erythropoiesis. Because no replacement for renal erythropoietin is available, particular attention must be paid to less important, but partially correctable factors that contribute to anemia. Blood transfusion requirements can then be reduced to a minimum, together with the risks of hypersplenism, hepatitis, and sensitization of the patient to alloantigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836115

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

1.  Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.

Authors:  Robert N Foley; Bryan M Curtis; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

2.  Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial.

Authors:  Robert N Foley; Bryan M Curtis; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.